Target Audience and Goal Statement
This activity was developed for sleep specialists and other healthcare
providers with an interest in sleep disorders.
Upon completion of this activity, participants will be able to:
- List the physiologic, psychological, pharmacologic, and
environmental risk factors that increase vulnerability to
insomnia.
- Explain the clinical implications of insomnia with regard to its
impact on physical and cognitive impairment, psychosocial
functioning, and health-related quality of life.
- Recognize insomnia as an independent risk factor for medical and
psychiatric comorbidities.
- Design an effective and individualized management plan for
patients with insomnia, utilizing appropriate pharmacologic and
nonpharmacologic treatment strategies.
Author(s)
-
Karl Doghramji, MD
Professor of Psychiatry, Jefferson Medical College, Philadelphia, Pennsylvania; Director, Sleep Disorders Center, Thomas Jefferson
University, Philadelphia, Pennsylvania
Disclosures
Disclosure: Grants/research support: Bristol-Myers Squibb, GlaxoSmithKline, Orphan Pharmaceuticals, Sanofi; Consultant: Pfizer
Inc, Takeda; Speakers bureau: Forest Laboratories, Inc., GlaxoSmithKline, King, Sanofi, Sepracor; Stock shareholder: Cephalon,
DuPont, Forest Laboratories, Inc., Merck & Co., Inc., Pfizer Inc.
-
Sonia Ancoli-Israel, PhD
Professor of Psychiatry; Director, Gillin Laboratory of Sleep and Chronobiology, University of California, San Diego
Disclosures
Disclosure: Grants/research support: National Institutes of Health; Consultant: Acadia, Cephalon, King, Neurocrine Biosciences,
Inc., Pfizer Inc, Sanofi-Aventis, Sepracor, Takeda; Stock shareholder: Cephalon, Neurocrine Biosciences, Inc., Pfizer Inc;
Honoraria: Acadia, Cephalon, King, Neurocrine Biosciences, Inc., Pfizer Inc, Sanofi-Aventis, Sepracor, Takeda.
-
Daniel J. Buysse, MD
Professor of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Director, Clinical Neuroscience
Research Center, Pittsburgh, Pennsylvania; Medical Director, Sleep and Chronobiology Program, Western Psychiatric Institute
and Clinic, Pittsburgh, Pennsylvania
Disclosures
Disclosure: Grants/research support/honoraria: Pfizer Inc, Sanofi-Aventis, Sepracor, Takeda; Consultant: Actelion, Cephalon,
Eli Lilly and Company, Merck & Co., Inc, Neurocrine Biosciences, Inc., Pfizer Inc, Respironics, Sanofi-Aventis, Servier, Sepracor,
and Takeda.
-
Michael Sateia, MD, Chair
Professor of Psychiatry, Dartmouth Medical School, Hanover, New Hampshire; Director, Dartmouth-Hitchcock Sleep Disorders Center,
Lebanon, New Hampshire
Disclosures
Disclosure: Consultant: Pfizer Inc, Takeda.
Accreditation Statements
For Physicians
-
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council
for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Wisconsin School of Medicine and
Public Health and CME Enterprise. The University of Wisconsin School of Medicine and Public Health is accredited by the ACCME
to provide continuing medical education for physicians.
The University of Wisconsin Medical School designates this educational
activity for a maximum of 2.0 Category 1 credits toward the AMA
Physician's Recognition Award. Each physician should claim only those
credits that he/she actually spent in the activity.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this
online educational activity. For information on applicability and
acceptance of continuing education credit for this activity, please
consult your professional licensing board.
This activity is designed to be completed within the time
designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To
successfully earn credit, participants must complete the activity
online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author
disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive
a certificate, you must receive a passing score as designated at the
top of the test. In addition, you must complete the Activity
Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE
Tracker. You may print the certificate but you cannot alter it. Credits
will be tallied in your CME/CE Tracker and archived for 5 years; at any
point within this time period you can print out the tally as well as
the certificates by accessing "Edit Your Profile" at the top of your
Medscape homepage.
*The credit that you receive is based on your user profile.
